163 related articles for article (PubMed ID: 36974561)
1. Trends in the Incidence of Kaposi's Sarcoma and Non-Hodgkin Lymphoma in Northern Thailand during the Time Period of Universal Access to Antiretroviral Treatment, 1998-2017.
Sripan P; Rerkasem A; Pongnikorn D; Chitapanarux I; Tangmunkongvorakul A; Ukranun W; Daoprasert K; Waisri N; Maneesai P; Srithanaviboonchai K; Aurpibul L
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1055-1061. PubMed ID: 36974561
[TBL] [Abstract][Full Text] [Related]
2. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
3. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
4. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
5. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
6. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
7. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy.
Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM
AIDS; 2001 Mar; 15(5):629-33. PubMed ID: 11317001
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries.
Casabona J; Melbye M; Biggar RJ
Int J Cancer; 1991 Jan; 47(1):49-53. PubMed ID: 1985878
[TBL] [Abstract][Full Text] [Related]
9. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
11. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
[TBL] [Abstract][Full Text] [Related]
12. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Bahl S; Theis B; Nishri D; Marrett LD
Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS.
Serraino D; Franceschi S
AIDS; 1996 Jun; 10(6):643-7. PubMed ID: 8780819
[TBL] [Abstract][Full Text] [Related]
14. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
15. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.
Jones JL; Hanson DL; Dworkin MS; Ward JW; Jaffe HW
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S11-7. PubMed ID: 10430212
[TBL] [Abstract][Full Text] [Related]
16. ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN'S LYMPHOMA AND KAPOSI'S SARCOMA.
Petroianu A; Alberti LR; Orsi VL; Viana FCT; Moura CB
Arq Bras Cir Dig; 2020; 33(2):e1521. PubMed ID: 33237165
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
18. High frequency of non-Hodgkin's lymphoma in patients with HIV-associated Kaposi's sarcoma.
Ridolfo AL; Santambrogio S; Mainini F; Vago L; Gervasoni C; Gori A; Parravicini C; Monforte A; Galli M
AIDS; 1996 Feb; 10(2):181-5. PubMed ID: 8838706
[TBL] [Abstract][Full Text] [Related]
19. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
20. Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations.
Chaabna K; Boniol M; de Vuyst H; Vanhems P; Antônio de Ávila Vitoria M; Curado MP
Eur J Cancer Prev; 2012 Jan; 21(1):1-9. PubMed ID: 21955799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
